Neuroone Medical Technologies (NMTC) Depreciation & Amortization (CF) (2019 - 2026)
Neuroone Medical Technologies posted quarterly Depreciation & Amortization (CF) of $60029.0 for Q1 2026, down 8.54% year-on-year from $65634.0 in Q1 2025, and down 8.38% on a QoQ basis from $65523.0 in Q4 2025.
Neuroone Medical Technologies (NMTC) has 8 years of Depreciation & Amortization (CF) data on file, last reported at $60029.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 8.54% year-over-year to $60029.0; the trailing twelve-month figure through Mar 2026 stood at $256470.0 (down 0.59% YoY), and the FY2025 full-year result was $261679.0, up 6.03% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $60029.0, down from $65523.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $66594.0 in Q2 2025 and bottomed at $28531.0 in Q1 2022.
- The 5-year median for Depreciation & Amortization (CF) is $60900.0 (2024), against an average of $54514.5.
- The widest annual swing landed in 2023, when Depreciation & Amortization (CF) surged 87.03%; it then slipped 8.54% in 2026.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $35889.0 in 2022, then surged by 63.44% to $58657.0 in 2023, then climbed by 11.03% to $65127.0 in 2024, then rose by 0.61% to $65523.0 in 2025, then decreased by 8.38% to $60029.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $60029.0 (Q1 2026), $65523.0 (Q4 2025), and $64324.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 123.40 Mn |
| 10 | Neuroone Medical Technologies | 31.39 Mn | 28.59 Mn | 1.29 Mn | 60,029.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60,029.00 |
| Mar 31, 2026 | 60,029.00 |
| Dec 31, 2025 | 65,523.00 |
| Dec 31, 2025 | 65,523.00 |
| Sep 30, 2025 | 64,324.00 |
| Sep 30, 2025 | 64,324.00 |
| Jun 30, 2025 | 66,594.00 |
| Jun 30, 2025 | 66,594.00 |
| Mar 31, 2025 | 65,634.00 |
| Mar 31, 2025 | 65,634.00 |
| Dec 31, 2024 | 65,127.00 |
| Dec 31, 2024 | 65,127.00 |
| Sep 30, 2024 | 64,127.00 |
| Sep 30, 2024 | 64,127.00 |
| Jun 30, 2024 | 63,107.00 |
| Jun 30, 2024 | 63,107.00 |
| Mar 31, 2024 | 60,900.00 |
| Mar 31, 2024 | 60,900.00 |
| Dec 31, 2023 | 58,657.00 |
| Dec 31, 2023 | 58,657.00 |
| Sep 30, 2023 | 62,509.00 |
| Sep 30, 2023 | 62,509.00 |
| Jun 30, 2023 | 56,958.00 |
| Jun 30, 2023 | 56,958.00 |
| Mar 31, 2023 | 43,910.00 |
| Mar 31, 2023 | 43,910.00 |
| Dec 31, 2022 | 35,889.00 |
| Dec 31, 2022 | 35,889.00 |
| Sep 30, 2022 | 33,422.00 |
| Sep 30, 2022 | 33,422.00 |
| Jun 30, 2022 | 31,506.00 |
| Jun 30, 2022 | 31,506.00 |
| Mar 31, 2022 | 28,531.00 |
| Mar 31, 2022 | 28,531.00 |
| Dec 31, 2021 | 25,161.00 |
| Dec 31, 2021 | 25,161.00 |
| Sep 30, 2021 | 22,363.00 |
| Sep 30, 2021 | 22,363.00 |
| Jun 30, 2021 | 20,355.00 |
| Jun 30, 2021 | 20,355.00 |
| Mar 31, 2021 | 19,294.00 |
| Mar 31, 2021 | 19,294.00 |
| Dec 31, 2020 | 18,736.00 |
| Dec 31, 2020 | 18,736.00 |
| Sep 30, 2020 | 13,767.00 |
| Sep 30, 2020 | 13,767.00 |
| Jun 30, 2020 | 12,877.00 |
| Jun 30, 2020 | 12,877.00 |
| Mar 31, 2020 | 11,067.00 |
| Mar 31, 2020 | 11,067.00 |
| Dec 31, 2019 | 9,898.00 |
| Dec 31, 2019 | 9,898.00 |
| Sep 30, 2019 | 10,942.00 |
| Sep 30, 2019 | 10,942.00 |
| Jun 30, 2019 | 694.00 |
| Jun 30, 2019 | 694.00 |